Bristol agrees to settle lawsuit over HIV drugs; the latest on UnitedHealth Group's bottom line

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      STAT+: Bristol Myers agrees to settle lawsuit alleging anti-competitive deals involving HIV drugs By Ed Silverman Courtesy Bristol Myers Squibb BMS has agreed to pay up to $11 million to settle a lawsuit that accused several drugmakers of conspiring to block generic competition. Read More STAT+: Omicron's speedy retreat helped bolster UnitedHealth Group's bottom line By Bob Herman Jim Mone/AP The Omicron surge didn’t lead to an explosion of medical claims at UnitedHealth Group, which contributed to higher-than-expect profits. Read More Listen: Leana Wen on the pandemic's new normal and whether Twitter is real life By Damian Garde and Meg Tirrell and Adam Feuerstein Doctor and professor Leana Wen joins us to talk about the many complexities of living with Covid and the tricky task of defining "normal." Read More Sponsor content by RARE ACCESS ACTION PROJECT Rare disease patients deserve protection from Washington politics Right now, politicians need a win, but rare disease patients could lose. In Congress' rush to pass something, therapies for rare diseases and cancers could face an increase of between 400% and 800% in Medicare Part D costs. There is a better way that protects patients. Learn more. STAT+: Hospitals have been financially propping up medical schools, but now it's squeezing their bottom lines By Tara Bannow Molly Ferguson for STAT Cash-strapped med schools have long relied on hospital money, but the transfers are getting attention as executives try to shore up finances. Read More Thursday, April 14, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser